Source:http://linkedlifedata.com/resource/pubmed/id/19671806
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2009-8-12
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0315-162X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1565-7
|
pubmed:meshHeading |
pubmed-meshheading:19671806-Arthritis, Rheumatoid,
pubmed-meshheading:19671806-Autoantibodies,
pubmed-meshheading:19671806-Health Status,
pubmed-meshheading:19671806-Humans,
pubmed-meshheading:19671806-Peptides, Cyclic,
pubmed-meshheading:19671806-Questionnaires,
pubmed-meshheading:19671806-Rheumatology
|
pubmed:year |
2009
|
pubmed:articleTitle |
Anti-cyclic citrullinated peptide antibody versus HAQ/MDHAQ: comparing apples and oranges?
|
pubmed:publicationType |
Editorial,
Comment
|